Clinical Trials
2 trialsNCT03899467 2024-02-12
The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC
Suzhou Kintor Pharmaceutical Inc,
Phase 2 Completed
NCT05076851 2021-10-13
Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown